Literature DB >> 7614736

Increased synovial expression of the adhesion molecules CD66a, CD66b, and CD31 in rheumatoid and osteoarthritis.

Z Szekanecz1, G K Haines, L A Harlow, M R Shah, T W Fong, R Fu, S J Lin, A E Koch.   

Abstract

Leukocyte-endothelial interaction mediated by adhesion molecules may play a role in the ingress of inflammatory cells into the rheumatoid (RA) synovial tissue (ST). A number of these molecules have been shown to be up-regulated in the inflamed compared to normal ST. We studied the distribution of two members of the CD66 carcinoembryonic antigen adhesion molecule family, as well as that of CD31, an antigen structurally related to CD66, on various cell types in the RA compared to osteoarthritic (OA) and normal ST. Immunoperoxidase histochemistry was carried out using monoclonal antibodies to CD66a, CD66b, and CD31. This study was performed on ST from 10 patients with RA, 10 with OA, and 4 normal individuals. CD66a, and CD66b were expressed on RA and OA ST myeloid cells but not on normal ST lining cells and interstitial macrophages, suggesting that these antigens may be specific markers of diseased compared to normal ST macrophages (P < 0.05). CD31 was present on more RA and OA than on normal ST macrophages. Also, CD31 was present on most RA, OA, and normal ST endothelial cells. Our results indicate that the expression of CD66a, CD66b, and CD31, members of the immunoglobulin superfamily of adhesion receptors, is up-regulated on cells of myeloid origin in the inflamed compared to normal ST. These results suggest that the CD66 antigens and CD31 may be involved in the adhesive events in the inflamed synovium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614736     DOI: 10.1006/clin.1995.1113

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  9 in total

Review 1.  Cellular adhesion molecules. Newly identified mediators of angiogenesis.

Authors:  P J Polverini
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

2.  Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues.

Authors:  Z Szekanecz; G K Haines; A E Koch
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

3.  The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis.

Authors:  Mae-Xhum Wong; John D Hayball; P Mark Hogarth; Denise E Jackson
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

4.  PECAM-1 gene polymorphisms and soluble PECAM-1 level in rheumatoid arthritis and systemic lupus erythematosus patients: any link with clinical atherosclerotic events?

Authors:  Omer Nuri Pamuk; Hilmi Tozkir; Mehmet Sevki Uyanik; Hakan Gurkan; Fatih Saritas; Julide Duymaz; Salim Donmez; Metin Yazar; Gulsum Emel Pamuk
Journal:  Clin Rheumatol       Date:  2014-09-10       Impact factor: 2.980

5.  Tumor-Associated Antigens in Rheumatoid Arthritis Interstitial Lung Disease or Malignancy?

Authors:  Gökhan Sargin; Reyhan Köse; Taşkın Şentürk
Journal:  Arch Rheumatol       Date:  2018-01-29       Impact factor: 1.472

Review 6.  Cell-cell interactions in synovitis. Endothelial cells and immune cell migration.

Authors:  Z Szekanecz; A E Koch
Journal:  Arthritis Res       Date:  2000-07-03

7.  Endotracheal tube-induced sore throat pain and inflammation is coupled to the release of mitochondrial DNA.

Authors:  Carlos A Puyo; Daniela Peruzzi; Alexander Earhart; Evan Roller; Menelaos Karanikolas; Marin H Kollef; Alexander S Krupnick; Daniel Kreisel; Mohsen Ibrahim; Andrew E Gelman
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

8.  Senolytic drugs relieve pain by reducing peripheral nociceptive signaling without modifying joint tissue damage in spontaneous osteoarthritis.

Authors:  Tae-Hwan Gil; Haiyan Zheng; Hyo Gyeong Lee; Ji-Won Shin; Sun Wook Hwang; Ki-Mo Jang; Ok Hee Jeon
Journal:  Aging (Albany NY)       Date:  2022-08-10       Impact factor: 5.955

9.  Endogenous opioids in wound-site neutrophils of sternotomy patients.

Authors:  Hamdy Awad; Motaz Abas; Haytham Elgharably; Ravi Tripathi; Tykie Theofilos; Sujatha Bhandary; Chittoor Sai-Sudhakar; Chandan K Sen; Sashwati Roy
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.